Status:

RECRUITING

A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis

Lead Sponsor:

Panafina, Inc.

Conditions:

Acute Pancreatitis

Eligibility:

All Genders

18-85 years

Phase:

PHASE2

Brief Summary

The goal of this clinical trial is to test the safety and effectiveness of a single dose of RABI-767 given by endoscopic ultrasound (EUS) guided peripancreatic injection in participants with predicted...

Eligibility Criteria

Inclusion

  • Key
  • Diagnosis of acute pancreatitis
  • Predicted severe acute pancreatitis, based on protocol defined criteria
  • Lack of clinically meaningful improvement from status at admission, at the discretion of Investigator, at the time of randomization
  • Suitable for EUS-guided study drug administration procedure
  • Contrast-enhanced computed tomography (CECT) or magnetic resonance imaging (MRI) of the abdomen/pancreas available for the evaluation of exclusion criteria
  • Key

Exclusion

  • Confirmed severe acute pancreatitis as defined by the Revised Atlanta Classification of Acute Pancreatitis (ie, Persistent \[\> 48 hours\] organ failure, per Modified Marshall Score), prior to randomization
  • Anticipated discharge from hospital within 48 hours of randomization
  • More than 30% pancreatic necrosis on screening CECT or MRI
  • History of previous pancreatic necrosis, including necrosectomy
  • History of calcific chronic pancreatitis
  • Evidence of cholangitis

Key Trial Info

Start Date :

June 28 2024

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

June 1 2026

Estimated Enrollment :

36 Patients enrolled

Trial Details

Trial ID

NCT06080789

Start Date

June 28 2024

End Date

June 1 2026

Last Update

December 24 2025

Active Locations (14)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 4 (14 locations)

1

University of Arkansas for Medical Sciences

Little Rock, Arkansas, United States, 72205

2

Keck Hospital of USC and LA County Hospital

Los Angeles, California, United States, 90033

3

University of Colorado Anschutz Medical Campus

Aurora, Colorado, United States, 80045

4

University of Florida Health

Gainesville, Florida, United States, 32608

A Study to Evaluate the Safety and Efficacy of a Single Dose of RABI-767 in Participants With Acute Pancreatitis | DecenTrialz